Pictet Asset Management (UK)’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-12,500
Closed -$56K 1809
2020
Q4
$56K Hold
12,500
﹤0.01% 1727
2020
Q3
$54K Buy
+12,500
New +$89.2K ﹤0.01% 1538
2017
Q1
Sell
-653,394
Closed -$2.58M 861
2016
Q4
$2.58M Buy
653,394
+20,018
+3% +$147K 0.01% 708
2016
Q3
$6.64M Buy
633,376
+386,884
+157% +$5.56M 0.03% 520
2016
Q2
$4.09M Buy
246,492
+25,280
+11% +$432K 0.02% 623
2016
Q1
$3.57M Buy
221,212
+4,341
+2% +$87.7K 0.02% 603
2015
Q4
$5.24M Buy
216,871
+46,589
+27% +$1.17M 0.02% 546
2015
Q3
$4.18M Buy
+170,282
New +$4.82M 0.02% 591

Other funds holding DVAX

Pictet Asset Management (UK)'s DVAX Position: Q1 2021 in Review

Pictet Asset Management (UK) sold out of Dynavax Technologies (DVAX) in Q1 2021, closing a stake of 12,500 shares — an estimated $56K sold.

Pictet Asset Management (UK) first reported a position in DVAX in Q3 2015 and held it in 8 quarters. The position peaked at $6.64M in Q3 2016. 162 funds tracked by Wall St. Rank hold DVAX as of Q1 2021.

  • Pictet Asset Management (UK) reported no remaining Dynavax Technologies position as of Q1 2021 after selling out during the quarter.
  • Pictet Asset Management (UK) sold 12,500 Dynavax Technologies shares in Q1 2021, an estimated $56K.
  • Pictet Asset Management (UK) first reported a position in Dynavax Technologies in Q3 2015 and held it in 8 quarters.
  • Pictet Asset Management (UK)'s Dynavax Technologies position peaked at $6.64M in Q3 2016.
  • 162 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q1 2021, filed 17 May 2021.